CACrown ArchivesThe cinema collection
Menu
Research dossier · Science & Nature

Current Oncology

scientific journal

Specimen drawers, botanical folios and brass scientific instruments under study light
Science and natureInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionAug 27, 2024
Entity authorityQ3498968
Source-derived summary

Current Oncology is a bi-monthly peer-reviewed medical journal covering oncology. It was established in 1994 and was originally published quarterly by Multimed Inc., a company founded in 1980 by Lorne Cooper. Its founders intended it to be a forum in which Canadian oncologists could publish their work. The journal is now published bimonthly by MDPI. All issues published since December 2005 are available fully open access on the journal's website. According to the Journal Citation Reports, the journal has a 2020 impact factor of 3.677.

Editorial summary

This brief starts where responsible research should: with the source description of “Current Oncology” as scientific journal. Everything that follows is an evidence route, not borrowed authority.

Editorial reviewA sound reference starting point where classification, measurement and the date of the underlying evidence remain visible. The current lead gives the account dated anchors—1994, 1980, 2005, 2020—that can be checked directly. The selected authority fields contribute no independent date. The account is most persuasive where Current, Oncology and scientific can be independently traced.
Editorial analysis

Why this record matters

The subject matters to the science & nature register because the source frames it as scientific journal. Its deeper value depends on whether names, dates, institutions and citations support that framing.

Evidence profile

The date and method of observation matter as much as the stated conclusion, especially where classification or consensus has changed. The source revision retrieved here is dated Aug 27, 2024. The linked authority identifier is Q3498968. 5 of 5 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 1994, 1980, 2005 and 2020.

Critical limits

A general summary may omit uncertainty, sample limits or methodological disagreement that is explicit in the technical record. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.

Best used for
  • Current terminology
  • Classification context
  • Finding cited technical literature
Verify next

Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.

Three-step research path

  1. Establish the record: confirm the title “Current Oncology”, its source revision and the description used here.
  2. Expand the search: follow Current Oncology primary sources, Current Oncology archive and Current research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Current Oncology”?
  2. Has classification or technical consensus changed since the cited source?
  3. Is the terminology current, historical or disputed?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from Current Oncology” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.